GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Raphas Co Ltd (XKRX:214260) » Definitions » Other Income (Expense)

Raphas Co (XKRX:214260) Other Income (Expense) : ₩1,171 Mil (TTM As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Raphas Co Other Income (Expense)?

Raphas Co's other income expense for the Raphas Co's pretax income for the three months ended in Mar. 2025 was ₩482 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₩1,171 Mil.

Raphas Co Other Income (Expense) Historical Data

The historical data trend for Raphas Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raphas Co Other Income (Expense) Chart

Raphas Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -349.58 9,280.76 -532.14 -819.98 1,474.20

Raphas Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 785.36 4,043.06 -8,039.00 4,684.78 481.83

Raphas Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,171 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raphas Co  (XKRX:214260) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Raphas Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Raphas Co Ltd (XKRX:214260) » Definitions » Other Income (Expense)
Comparable Companies
XKRX:338840 XKRX:251120 XKRX:456070 XKRX:048530 XKRX:311690 XKRX:278650 XKRX:084990 XKRX:235980 XKRX:299660 XKRX:376270 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
62, Magokjungang 8-ro 1-gil, Gangseo-gu, Seoul, KOR, 07793
Website
http://www.raphas.com
Raphas Co Ltd is engaged in the development of a drug delivery system. The company's products include Acropass, Cosmetics ODM, and Medical Contract Manufacturing Services. Its products are mostly used in biomedical products and all-natural cosmetic materials.

Raphas Co Headlines

No Headlines